3'-O-MOE-5MeU-2'-phosphoramidite manufacturers
|
| | 3'-O-MOE-5MeU-2'-phosphoramidite Basic information |
| Product Name: | 3'-O-MOE-5MeU-2'-phosphoramidite | | Synonyms: | 3'-O-MOE-5MeU-2'-phosphoramidite;5’-O-DMTr-3’-O-(2-methoxyethyl)-5-methyl uridine-2’-CED-phosphoramidite;Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-(2-methoxyethyl)-5-methyl-, 2'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI);3’-O-MOE-5MeU-2’-phosphoramidite;3-[({[(2R,3R,4R,5R)-5-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-4-(2-methoxyethoxy)-2-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-3-yl]oxy}(bis(propan-2-yl)amino)phosphanyl)oxy]propanenitrile;Thymidine, 4′,5′-didehydro-5′-deoxy- (9CI, ACI) | | CAS: | 256223-93-5 | | MF: | C43H55N4O10P | | MW: | 818.89 | | EINECS: | | | Product Categories: | | | Mol File: | 256223-93-5.mol |  |
| | 3'-O-MOE-5MeU-2'-phosphoramidite Chemical Properties |
| | 3'-O-MOE-5MeU-2'-phosphoramidite Usage And Synthesis |
| Uses | 3’-O-MOE-5MeU-2’-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 3'-O-MOE-5MeU-2'-phosphoramidite Preparation Products And Raw materials |
|